Although age-standardised mortality and DALY rates have declined, the growing absolute number of cases, recent upward shift in incidence, and persistent concentration of burden among children, older adults, and lower-SDI settings point to continuing gaps in prevention, surveillance, diagnosis, and care.
Abstract
Background
Encephalitis remains a major cause of neurological morbidity and mortality worldwide, particularly in resource-limited settings. This study analyzed the long-term trends and disparities in encephalitis burden across 131 low- and middle-income countries (LMICs) from 1990 to 2023.
Methods
Data were obtained from the Global Burden of Disease 2023 study for 131 LMICs. Incidence, prevalence, deaths, and disability-adjusted life years (DALYs) were analysed using absolute counts and age-standardised rates. Trends were assessed with estimated annual percentage changes, joinpoint regression, age-period-cohort analysis, correlations with socio-demographic index (SDI), and decomposition analysis.
Results
In 2023, encephalitis in LMICs caused 1.59 million incident cases, 5.21 million prevalent cases, 70,042 deaths, and 4.07 million DALYs. From 1990 to 2023, incident cases increased by 24.7%, while the age-standardised incidence rate fell from 29.57 to 25.15 per 100,000 person-years (EAPC, -0.71; 95% CI, -0.83 to -0.59). Age-standardised mortality and DALY rates also declined, with EAPCs of -1.97 and -2.20. Incidence reached a low point around 2010 before rising again, particularly after 2019. The burden was greatest in children and older adults. Higher SDI was associated with lower age-standardised incidence, mortality, and DALY rates (r = -0.59, -0.41, and -0.56, respectively; all P < 0.001). Population growth accounted for most of the increase in case numbers.
Conclusion
Encephalitis remains a substantial health burden in LMICs. Although age-standardised mortality and DALY rates have declined, the growing absolute number of cases, recent upward shift in incidence, and persistent concentration of burden among children, older adults, and lower-SDI settings point to continuing gaps in prevention, surveillance, diagnosis, and care.
Despite global progress, marked inequalities persist, and forecasts indicate continued prevalence rise and substantial mortality reduction by 2031, with persistent inequalities.
Mei Zhao, Chun-Mei Qiu, Li-ping Cai et al.· Journal of Maternal-Fetal &...· 0 citations
Background: Meningitis remains a major cause of global morbidity and mortality. We aimed to quantify the association between vaccine introduction and meningitis-related disability-adjusted life year (DALY) rates globally and across high-burden regions from 2000 to 2023. Methods: We conducted a longitudinal panel study...
BACKGROUND
Multiple myeloma (MM) results in significant mortality and disability; however, long-term trends and forecasts specific to Mexico remain insufficiently characterized.
METHODS
A secondary analysis of Global Burden of Disease (GBD) estimates for Mexico (1990-2023) was conducted. Incidence, prevalence, deaths...
J. Solis-Poblano, Jorge Luis López-Marthen, Patricia Zagoya-Martínez et al.· Archives of Medical Research· 0 citations
The burden of meningitis in the WPR declined substantially from 1990 to 2023, but persistent cross-country inequalities and shifts in age-specific and pathogen-specific patterns remained.
Seungjae Byun, Yeongtaek Hwang, Ye-Jun Son et al.· Journal of Travel Medicine· 0 citations
Incidence was strongly associated with mortality in low-income settings but largely decoupled from mortality in upper-middle-income settings, and the burden was mostly concentrated in South Asia, Sub-Saharan Africa, and lower-middle-income countries.
The findings highlight the need for targeted strategies to improve early diagnosis and reduce the burden of myocarditis, particularly in vulnerable populations and lower-resource settings, while being interpreted in the context of evolving diagnostic and coding practices.
Sooji Lee, Hayeon Lee, Min Seo Kim et al.· Journal of the American Coll...· 1 citation
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.